| Product Name | MF | CAS | Details |
|---|
| 2-(2-Bromo-6-chlorophenyl)amino)-phenylacetic acid sodium salt 95% | C14H10BrClNNaO2 | 127792-45-4 | Details |
| 7-[(2-Aminopropyl)amino]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid | C17H20FN3O4 | 172426-87-8 | Details |
| IMp. H (EP): (2R)-2-[(2,2-DiMethylpropanoyl)aMino]-2-(4-hydroxyphenyl)acetic Acid | C16H19N3O5S | Details |
| BendaMustine IMpurity | Details |
| Mycophenolate IMpurity | Details |
| Diclofenac | Details |
| Quinapril IMpuriy | Details |
| Aceclofenac | C16H13Cl2NO4 | 89796-99-6 | Details |
| Pramipexole | C10H17N3S | 104632-26-0 | Details |
| Amlodipine EP Impurity D | C20H23ClN2O5 | 113994-41-5 | Details |
| Sertraline IMpurity (SRTRC-3) | C17H17Cl2N | Details |
| Pantoprazole IMpurity (Mixture of IMpurity D and F) | Details |
| Ceftizoxime | C13H13N5O5S2 | 102044-69-9 | Details |
| 2-Hydroxybenzimidazole | C7H6N2O | 615-16-7 | Details |
| Buspirone | C21H31N5O2 | 36505-84-7 | Details |
| AMOXICILLIN TRIHYDRATE IMP. E (EP): (2RS,4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]METHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID (PENILLOIC ACIDS OF AMOXICILLIN) | Details |
| Meloxicam | C14H13N3O4S2 | 71125-38-7 | Details |
| Mirabegron | C21H24N4O2S | 223673-61-8 | Details |
| Duloxetine impurity A | Details |
| Ciprofloxacin impurity C | C17H18FN3O3 | Details |
| NiMesulide EP IMpurity E | Details |
| Erlotinib Hydrochloride iMpurity | C22H23N3O5 | 882420-22-6 | Details |
| δ-2-CefodiziMe (2 :1 Mixture) | C20H20N6O7S4 | 120533-30-4 | Details |
| Ticagrelor Impurity N | C23H29FN6O4S | 1643378-47-5 | Details |
| Pregabalin Diacid | C16H26N2O | 1788341-42-3 | Details |
| LETROZOLE RELATED COMPOUND A (25 MG) (4,4'-(1H-1,3,4-TRIAZOL-1 -YLMETHYLENE)DIBENZONITRILE) | Details |
| Gabapentin Related Compound E | C9H14O4 | 67950-95-2 | Details |
| Amlodipine Dimethyl Ester | C19H23ClN2O5 | 140171-66-0 | Details |
| N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide | C25H22F6N4O2S | 1083100-27-9 | Details |
| (2RS)-1-[Benzyl[2-(2-Methoxy-phenoxy)ethyl]aMino]-3-(9H-carbazol-4-yloxy)propan-2-ol | C31H32N2O4 | Details |
| Fenofibrate IMpurity F | Details |
| Rabeprazole IMpurity G | Details |
| IMp. A (EP): 1-(DiphenylMethyl)piperazine | Details |
| Aprepitant iMpurity | C13H22NO4P | 96730-04-0 | Details |
| Lisinopril iMpurity | C21H31N3O5 | Details |
| Erlotinib | C13H17NO7 | 1384975-87-4 | Details |
| Bisoprolol IMpurity | C18H31NO4 | 2226263-67-6 | Details |
| Diltiazem impurity | C17H18N2O3S | 115992-91-1 | Details |
| Raloxifene EP IMpurity | C13H15ClN2O2S | 1700655-64-6 | Details |
| Bosentan | C27H29N5O6S | 147536-97-8 | Details |
| Pramipexole Impurity 14 | C7H6N2O | 4570-41-6 | Details |
| 2-Isopropoxyethyl 4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]-benzoate (Bisoprolol Ester) | C36H58N2O8 | Details |
| 5-(Propylsulphanyl)-1H-benziMidazol-2-aMine | C10H13N3S | Details |
| IMp. F (EP): 3-(4-Hydroxyphenyl)pyrazin-2-ol | Details |
| 1H-benzo[d]imidazol-2-ol | C7H6N2O | Details |
| Lercanidipine iMpurity | C37H43N3O6 | 320750-19-4 | Details |
| Clopidogrel | C16H16ClNO3S | 1319197-71-1 | Details |
| Ropinirole impurity | Details |
| Ampicillin | C16H25N3O7S | 7177-48-2 | Details |
| 3-[4-(2-Methoxyethyl)phenoxy]- | C12H18O4 | 62572-90-1 | Details |
| NiMesulide EP IMpurity F | Details |
| SalMeterol iMpurity | C25H37NO4 | 144391-74-2 | Details |
| 7-(4-Hydroxybutoxy-4,4-d2)-2(1H)-quinolinone | C13H13D2NO3 | 1008531-47-2 | Details |
| Hydrochlorothiazide | C7H8ClN3O4S2 | 58-93-5 | Details |
| Celecoxib Impurity 2 | C11H9F3N2 | 948293-46-7 | Details |
| RaMipril EP IMpurity A | C23H32N2O5 | Details |
| (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyriMidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | Details |
| Pioglitazone BroMo IMpurity | Details |
| NiMesulide IMpurity C (2-phenoxyaniline) | Details |
| AMbroxol CycloiMine IMpurity | C16H22Br2N2O3 | 73220-00-5 | Details |
| (2S,3'Z)-Cefprozil | C18H19N3O5S | 110764-35-7 | Details |
| DONEPEZIL IMP | C24H22NO4.Cl | 923571-16-8 | Details |
| Tiotropium Bromide Impurity | C9H16BrNO2 | 1044148-31-3 | Details |
| Cefoxitin Impurity | Details |
| Naftopidil dihydrochloride | C24H28N2O3 | 57149-07-2 | Details |
| Stugeron | C26H28N2 | 298-57-7 | Details |
| 2-Desisopropyl-2-phenyl Repaglinide | C30H34N2O4 | 107362-12-9 | Details |
| N-[2-[(Methylamino)carbonyl]benzoyl] | C29H32ClN3O7 | 721958-72-1 | Details |
| Ciprofloxacin impurity B | C17H18FN3O3 | Details |
| 9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine | C14H18ClN5O4 | 97845-60-8 | Details |
| (6S)-N,N ′-dipropyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6- diaMine | Details |
| 1,1'-[[2-(2-Methoxyphenoxy)ethyl]-nitrilo]bis [3-(9H carbazol- 4-yloxy)propan-2-ol] | Details |
| 1-[[9-[2-hydroxy-3-[[2-(2-Methoxyphenoxy)ethyl]aMino] propyl]-9H-carbazol-4-yl]oxy]-3-[[2-(2-Methoxyphenoxy) ethyl]aMino]propan-2-ol | C36H43N3O7 | Details |
| Ciprofloxacin IMpurity A | C17H18FN3O3 | Details |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4aR,7aS)-octahydropyrrolo [3,4-b]pyridin-6-yl)-8-Methoxy-4-oxoquinoline-3-carboxylic acid | C21H24FN3O4 | 1394029-14-1 | Details |
| (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile | C14H20N6O | 1640971-60-3 | Details |
| Fluticasone IMpurity | C27H30F2O6S | 397864-58-3 | Details |
| Bicalutamide | C18H14F4N2O4S | 90357-06-5 | Details |
| Ciprofloxacin IMpurity E | C17H18FN3O3 | Details |
| Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] | C25H18N2S2 | 2206135-50-2 | Details |
| Rabeprazole iMpurity (Chloro interMediate) | Details |
| Rivastigmine | C14H22N2O2 | 123441-03-2 | Details |
| 5-Methyl-4-isoxazolecarboxylic acid | C5H5NO3 | 42831-50-5 | Details |
| 3-Oxo-4-aza-5-alpha-androstane-17-beta-carboxylic acid | C19H29NO3 | 103335-55-3 | Details |
| N-(CyclohexylcarbaMoyl)-4-[2-[(cyclohexylcarbaMoyl) aMino] ethyl]benzenesulphonaMide | C22H34N4O4S | Details |
| IMp. B (EP): 2-[4-[(2RS)-2,3-Dihydroxypropoxy)phenyl]acetaMide | Details |
| Desmethyl Mirtazapine-d4 | C16H17N3 | 1188331-80-7 | Details |
| Diacerein IMpurity F | C35H36O16 | 13928-72-8 | Details |
| Paroxetine IMpurity | Details |
| PiroxicaM IMpurity ( N-(2-Pyridinyl)oxaMic Acid ) | Details |
| 4-[2-[(CyclohexylcarbaMoyl)aMino]-ethyl] benzenesulphonaMide | C15H23N3O3S | Details |
| OMEPRAZOLE IMPURITY D (EP):5-METHOXY-2-[[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHYL]SULPHONYL]-1H-BENZIMIDAZOLE (OMEPRAZOLE SULPHONE) MM STANDARD | C17H19N3O3S | Details |
| Fenofibrate Related Compound C | Details |
| OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD | C17H19N3O3S | Details |
| (6R-trans)-7-amino-8-oxo-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C10H10N4O3S3 | 24209-43-6 | Details |
| NITRENDIPINE IMPURITY A | Details |
| (2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETAMIDE | C15H21N3O4S | 178738-48-2 | Details |
| IMp. E (EP): 1,4-Bis(diphenylMethyl)piperazine | C30H30N2 | 216581-01-0 | Details |
| Ramipril Related Compound B | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||